A detailed history of Pnc Financial Services Group, Inc. transactions in Amgen Inc stock. As of the latest transaction made, Pnc Financial Services Group, Inc. holds 1,068,066 shares of AMGN stock, worth $338 Million. This represents 0.22% of its overall portfolio holdings.

Number of Shares
1,068,066
Previous 1,081,289 1.22%
Holding current value
$338 Million
Previous $307 Million 8.55%
% of portfolio
0.22%
Previous 0.21%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

SELL
$262.75 - $319.31 $3.47 Million - $4.22 Million
-13,223 Reduced 1.22%
1,068,066 $334 Million
Q1 2024

May 10, 2024

SELL
$268.87 - $324.56 $5.51 Million - $6.65 Million
-20,491 Reduced 1.86%
1,081,289 $307 Million
Q4 2023

Feb 09, 2024

BUY
$255.7 - $288.46 $2.83 Million - $3.19 Million
11,067 Added 1.01%
1,101,780 $317 Million
Q3 2023

Nov 13, 2023

BUY
$218.65 - $271.46 $9.2 Million - $11.4 Million
42,092 Added 4.01%
1,090,713 $293 Million
Q2 2023

Aug 11, 2023

SELL
$214.27 - $253.37 $13.6 Million - $16.1 Million
-63,466 Reduced 5.71%
1,048,621 $233 Million
Q1 2023

May 15, 2023

SELL
$225.79 - $275.2 $5.86 Million - $7.14 Million
-25,960 Reduced 2.28%
1,112,087 $269 Million
Q4 2022

Feb 10, 2023

SELL
$229.03 - $291.01 $4.13 Million - $5.25 Million
-18,045 Reduced 1.56%
1,138,047 $299 Million
Q3 2022

Nov 10, 2022

SELL
$224.46 - $253.15 $4.12 Million - $4.65 Million
-18,371 Reduced 1.56%
1,156,092 $261 Million
Q2 2022

Aug 12, 2022

SELL
$230.71 - $256.74 $1.86 Million - $2.07 Million
-8,062 Reduced 0.68%
1,174,463 $286 Million
Q1 2022

May 12, 2022

SELL
$219.27 - $242.57 $6.21 Million - $6.87 Million
-28,309 Reduced 2.34%
1,182,525 $286 Million
Q4 2021

Feb 11, 2022

SELL
$198.88 - $227.6 $52.1 Million - $59.7 Million
-262,173 Reduced 17.8%
1,210,834 $272 Million
Q3 2021

Nov 05, 2021

SELL
$212.27 - $248.7 $18.7 Million - $21.9 Million
-88,030 Reduced 5.64%
1,473,007 $313 Million
Q2 2021

Aug 06, 2021

SELL
$233.58 - $259.14 $3.33 Million - $3.7 Million
-14,264 Reduced 0.91%
1,561,037 $381 Million
Q1 2021

May 07, 2021

SELL
$221.91 - $258.6 $17.5 Million - $20.4 Million
-78,955 Reduced 4.77%
1,575,301 $392 Million
Q4 2020

Feb 12, 2021

SELL
$216.38 - $257.67 $11.9 Million - $14.1 Million
-54,801 Reduced 3.21%
1,654,256 $380 Million
Q3 2020

Nov 06, 2020

BUY
$234.65 - $260.95 $623,230 - $693,083
2,656 Added 0.16%
1,709,057 $434 Million
Q2 2020

Aug 07, 2020

SELL
$197.81 - $242.74 $5 Million - $6.14 Million
-25,278 Reduced 1.46%
1,706,401 $402 Million
Q1 2020

May 08, 2020

SELL
$182.24 - $241.7 $25.5 Million - $33.9 Million
-140,186 Reduced 7.49%
1,731,679 $351 Million
Q4 2019

Feb 07, 2020

SELL
$189.21 - $243.2 $3.98 Million - $5.11 Million
-21,021 Reduced 1.11%
1,871,865 $451 Million
Q3 2019

Nov 08, 2019

SELL
$174.11 - $208.62 $7.91 Million - $9.48 Million
-45,435 Reduced 2.34%
1,892,886 $366 Million
Q2 2019

Aug 09, 2019

SELL
$166.7 - $195.41 $8.48 Million - $9.94 Million
-50,853 Reduced 2.56%
1,938,321 $0
Q1 2019

May 10, 2019

SELL
$180.87 - $203.88 $11.9 Million - $13.5 Million
-66,017 Reduced 3.21%
1,989,174 $0
Q4 2018

Feb 08, 2019

SELL
$178.4 - $208.25 $11.3 Million - $13.2 Million
-63,219 Reduced 2.98%
2,055,191 $400 Million
Q3 2018

Nov 09, 2018

SELL
$185.29 - $208.89 $452,663 - $510,318
-2,443 Reduced 0.12%
2,118,410 $0
Q2 2018

Aug 10, 2018

SELL
$166.05 - $186.51 $1.08 Million - $1.21 Million
-6,484 Reduced 0.3%
2,120,853 $0
Q1 2018

May 11, 2018

BUY
$169.43 - $198.0 $1.92 Million - $2.24 Million
11,327 Added 0.54%
2,127,337 $0
Q4 2017

Feb 09, 2018

SELL
$168.79 - $188.59 $1.07 Million - $1.2 Million
-6,342 Reduced 0.3%
2,116,010 $0
Q3 2017

Nov 13, 2017

BUY
$167.29 - $191.0 $355 Million - $405 Million
2,122,352
2,122,352 $0

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $169B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Pnc Financial Services Group, Inc. Portfolio

Follow Pnc Financial Services Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pnc Financial Services Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Pnc Financial Services Group, Inc. with notifications on news.